Iovance Biotherapeutics Inc. Common Stock vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.58 (market cap $6.04B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.61 (market cap $330.98M). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 18.2× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| IOVA | XDTE | |
|---|---|---|
Market Cap | $6.04B | $330.98M |
Volume | 14,805,993 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $14.82 | $44.76 |
52-Week Low | $1.81 | $36.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $5.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →